Brevan Howard Capital Management’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
56,568
+27,216
+93% +$171K ﹤0.01% 1662
2026
Q1
$178K Sell
29,352
-113,159
-79% -$662K ﹤0.01% 1929
2025
Q4
$1.02M Buy
142,511
+33,922
+31% +$241K 0.01% 756
2025
Q3
$820K Sell
108,589
-22,002
-17% -$161K ﹤0.01% 997
2025
Q2
$815K Buy
130,591
+102,891
+371% +$476K ﹤0.01% 1153
2025
Q1
$86.4K Sell
27,700
-49,174
-64% -$173K ﹤0.01% 1061
2024
Q4
$304K Buy
+76,874
New +$270K ﹤0.01% 770

Other funds holding EVLV

Brevan Howard Capital Management's EVLV Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Evolv Technologies (EVLV) stake by 93% in Q2 2026, buying an estimated $171K and bringing the position to 56,568 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

Brevan Howard Capital Management first reported a position in EVLV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.02M in Q4 2025. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Brevan Howard Capital Management held 56,568 shares of Evolv Technologies worth $328K as of Q2 2026.
  • Brevan Howard Capital Management bought 27,216 Evolv Technologies shares in Q2 2026, an estimated $171K.
  • Evolv Technologies made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1662 holding.
  • Brevan Howard Capital Management first reported a position in Evolv Technologies in Q4 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Evolv Technologies position peaked at $1.02M in Q4 2025.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.